Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-07-02 / Signal Transduct Target Ther 2020 Jul;5(1):114https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-07-02 / Signal Transduct Target Ther 2020 Jul;5(1):1142020-07-02 00:00:002020-07-02 00:00:00Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-07-01 / Discov Med 2020 Jul-Aug;30(159):39-48https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-07-01 / Discov Med 2020 Jul-Aug;30(159):39-482020-07-01 00:00:002020-07-01 00:00:00Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-07-01 / J Immunother Cancer 2020 07;8(2)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-07-01 / J Immunother Cancer 2020 07;8(2)2020-07-01 00:00:002021-05-12 07:32:39Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-06-29 / Cancer Cell Int. 2020;20:278https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-06-29 / Cancer Cell Int. 2020;20:2782020-06-29 00:00:002020-06-29 00:00:00Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-06-12 / Front Oncol 2020;10:819https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-06-12 / Front Oncol 2020;10:8192020-06-12 00:00:002020-06-12 00:00:00Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-06-02 / Sci Rep 2020 Jun;10(1):8936https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-06-02 / Sci Rep 2020 Jun;10(1):89362020-06-02 00:00:002020-06-02 00:00:00Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-05-22 / Immunotargets Ther 2020;9:95-104https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-05-22 / Immunotargets Ther 2020;9:95-1042020-05-22 00:00:002020-05-22 00:00:00Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-05-21 / Front Immunol 2020;11:924https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-05-21 / Front Immunol 2020;11:9242020-05-21 00:00:002020-05-21 00:00:00Dendritic Cells and Their Role in Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002020-05-19 / Medicines (Basel) 2020 May;7(5)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2020-05-19 / Medicines (Basel) 2020 May;7(5)2020-05-19 00:00:002021-11-15 20:10:42Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus
Hyperthermia treatment advances for brain tumors
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review
Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
IOZK analysis proves good tolerability of IOZK immunotherapy in diffuse intrinsic pontine glioma (DIPG)
Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
Dendritic Cells and Their Role in Immunotherapy
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience